Visual cortex disorder

disease
On this page

Also known as disease of visual cortexdisease or disorder of visual cortexdisorder of visual cortexvisual cortex diseasevisual cortex disease or disorder

Summary

Visual cortex disorder (MONDO:0003584) is a disease. A subtype of visual pathway disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: Unknown (Worldwide) [Orphanet-validated]
  • Phenotypes (HPO): 41

Clinical features

Signs & symptoms

Clinical features (HPO)

41 HPO clinical features (Orphanet curated; top 41 by frequency):

HPO IDTermFrequency
HP:0002500Abnormal cerebral white matter morphologyFrequent (30-79%)
HP:0100021Cerebral palsyFrequent (30-79%)
HP:0010794Impaired visuospatial constructive cognitionFrequent (30-79%)
HP:0001249Intellectual disabilityFrequent (30-79%)
HP:0001622Premature birthFrequent (30-79%)
HP:0410263Brain imaging abnormalityFrequent (30-79%)
HP:0002060Abnormal cerebral morphologyOccasional (5-29%)
HP:0000238HydrocephalusOccasional (5-29%)
HP:0011450Unusual CNS infectionOccasional (5-29%)
HP:0001250SeizureOccasional (5-29%)
HP:0025315Exacerbated by head traumaOccasional (5-29%)
HP:0002180NeurodegenerationOccasional (5-29%)
HP:0000252MicrocephalyOccasional (5-29%)
HP:0007009Central nervous system degenerationOccasional (5-29%)
HP:0000486StrabismusOccasional (5-29%)
HP:0000539Abnormality of refractionOccasional (5-29%)
HP:0000639NystagmusOccasional (5-29%)
HP:0012796Increased cup-to-disc ratioOccasional (5-29%)
HP:0000543Optic disc pallorOccasional (5-29%)
HP:0001141Severely reduced visual acuityOccasional (5-29%)
HP:0025405Visual fixation instabilityOccasional (5-29%)
HP:0007772Impaired smooth pursuitOccasional (5-29%)
HP:0001123Visual field defectOccasional (5-29%)
HP:0000736Short attention spanOccasional (5-29%)
HP:0007018Attention deficit hyperactivity disorderOccasional (5-29%)
HP:0000729Autistic behaviorOccasional (5-29%)
HP:0002312ClumsinessOccasional (5-29%)
HP:0000496Abnormality of eye movementOccasional (5-29%)
HP:0002140Ischemic strokeOccasional (5-29%)
HP:0001998Neonatal hypoglycemiaOccasional (5-29%)
HP:0002170Intracranial hemorrhageOccasional (5-29%)
HP:0032046Focal cortical dysplasiaOccasional (5-29%)
HP:0001287MeningitisOccasional (5-29%)
HP:0002383Infectious encephalitisOccasional (5-29%)
HP:0012443Abnormality of brain morphologyOccasional (5-29%)
HP:0030800Abnormal visual accommodationOccasional (5-29%)
HP:0500049Retinopathy of prematurityOccasional (5-29%)
HP:0000609Optic nerve hypoplasiaOccasional (5-29%)
HP:0000648Optic atrophyOccasional (5-29%)
HP:0000641Dysmetric saccadesOccasional (5-29%)
HP:0000657Oculomotor apraxiaOccasional (5-29%)

Identifiers

Disease identifiers

FieldValue
Canonical namevisual cortex disorder
Mondo IDMONDO:0003584
Orphanet447788
DOIDDOID:5691
ICD-10-CMH47.6
NCITC35275
SNOMED CT128329001
UMLSC0234398
MedGen66699
GARD0027642
Anatomy (UBERON)UBERON:0000411
Is cancer (heuristic)no

Also known as: disease of visual cortex · disease or disorder of visual cortex · disorder of visual cortex · visual cortex disease · visual cortex disease or disorder · visual cortex disorder

Disease family

This is a subtype of visual pathway disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disordercentral nervous system disorderbrain disordervisual pathway disordervisual cortex disorder

Related subtypes (4): retinal nerve fiber layer disorder, coloboma of optic nerve, optic pathway glioma, optic tract meningioma

Subtypes (2): cortical blindness, visual epilepsy

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.